Factor X

Topical RNA Delivery Platform for Precision Skin Longevity and Cosmetic Performance

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in December 2025 by Inbal Gat and Shira Orr, Factor X operates with 1–10 employees. The company closed a pre-seed funding round in July 2026.

Business overview

Factor X is developing a cosmetic-grade topical delivery platform designed to transport RNA and other active payloads across the skin barrier to specific skin layers. This technology aims to provide skincare and cosmetic partners with more precise, stable, and efficient formulations for applications such as skin longevity, UV-damaged skin repair, hair color, and hair regrowth. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Cosmetic Materials, serving enterprise and professional services, including SMBs and larger enterprises.

Strategic signal

In July 2026, Factor X closed a pre-seed funding round. This early-stage investment validates the market's interest in the company's innovative topical RNA delivery platform, signaling potential for disruption in the precision skincare and cosmetic performance industry. For investors, this indicates early traction and confidence in Factor X's technology to address advanced skin longevity and cosmetic challenges.

Log in to access full profile

Company Intelligence Q&A

What is Factor X's core technology?
Factor X is developing a cosmetic-grade topical delivery platform that carries RNA and other active payloads across the skin barrier to specific skin layers for enhanced skincare and cosmetic performance.
When was Factor X founded and by whom?
Factor X was founded in December 2025 by Inbal Gat and Shira Orr.
What was Factor X's most recent funding activity?
The funding was announced on July 13, 2026, as reported by Finsmes.com.
Which markets does Factor X target with its technology?
Factor X targets skincare and cosmetic partners seeking advanced formulations for skin longevity, UV-damaged skin, hair color, and hair regrowth applications.
What is the current product development stage for Factor X?
Factor X's product is currently in the Research & Development (R&D) stage, focusing on developing its topical RNA delivery platform.
Log in to access full profile